Osteopontin as a Biomarker in Pancreatitis (PtitStudien)

Linköping University (LiU)

Status: Completed

Conditions: Pancreatitis

Treatments: Other: No intervention, observation

Study type: Observational

Funder types: Other

Identifiers

NCT05882500

PtitStudien

Details and patient eligibility

About

In the early phase of pancreatits, factors that can give information about the development of severety are still lacking. In this study patients will be included prospectively upon the diagnosis of pancreatits and clinical as well as labarotory and radiological factors will be sampled. The aim is do identifiy factors that may aid in the risk stratification for development of different severity grades of pancreatitis.

Full description

In the early phase of pancreatits, factors that can give information about the development of severety are still lacking. In this study patients will be included prospectively upon the diagnosis of pancreatits and clinical as well as labarotory and radiological factors will be sampled. The aim is do identifiy factors that may aid in the risk stratification for development of different severity grades of pancreatitis.

Patients admitted and diagnosed with pancreatitis (according to the Atlanta criteria) will have serial testing of se-osteopontin in addiation to rutine blood work. Computet tomograpy and chest x-ray are mandatory as is blood culture.

Enrollment: 103 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of pancreatitis

Exclusion criteria

• Pregnancy, lactation, unable to understand the study

Trial design

103 participants in 1 patient group

Pancreatits

Description:

Patients with pancreatitis based ont the Atlanta criteria

Treatment:

Other: No intervention, observation